Skip to main content

Table 4 IPA summary of liver transcriptomes in hatcling chicks–D2FAST48h vs. D3REFED24h contrast

From: Transcriptome analyses of liver in newly-hatched chicks during the metabolic perturbation of fasting and re-feeding reveals THRSPA as the key lipogenic transcription factor

Top Canonical Pathways

p-value

Overlap

Ratio

Tryptophan Degradation III

4.58E-12

56.0%

14/25

NRF2-mediated Oxidative Stress Response

4.30E-09

17.1%

33/193

Super-pathway of Cholesterol Biosynthesis

8.44E-09

42.9%

12/28

Protein Ubiquitination Pathway

1.42E-08

14.7%

39/265

Fatty Acid -oxidation I

5.11E-08

37.5%

12/32

Top Upstream Regulators

p-value of overlap

# Target genes

HNF4A

5.44E-22

224

E2F1

6.07E-19

81

PPARA

9.50E-19

77

NFE2L2

4.82E-16

68

E2F4

7.81E-16

48

Top Molecular and Cellular Functions

p-value

# Genes

Cell Death and Survival

3.73E-04 - 9.50E-20

434

Cell Cycle

3.58E-04 - 7.37E-18

270

Cellular Assembly and Organization

2.92E-04 - 6.25E-17

103

DNA Replication, Recombination, and Repair

3.58E-04 - 6.25E-17

176

Amino Acid Metabolism

2.69E-04 - 2.67E-12

38

Physiological System Development and Function

p-value

# Genes

Organismal Survival

6.21E-09 - 2.57E-09

278

Digestive System Development and Function

1.35E-04 - 1.47E-07

82

Hepatic System Development and Function

4.62E-05 - 1.47E-07

53

Organ Morphology

3.43E-05 - 1.47E-07

52

Organismal Development

4.62E-05 - 1.47E-07

65

Up-regulated genes

FAST48h-REFED24h

Down-regulated genes

FAST48h-REFED24h

IGFBP2

3.19

THRSPA

−5.99

ADSL

3.19

ME1

−4.84

LDHB

2.90

SCD

−4.72

MBL2

2.85

LGALS2

−3.65

ALB

2.71

CYP51A1

−3.30

CYP4A22

2.66

PLIN2

−3.26

UPP2

2.61

FADS2

−3.24

BHMT

2.56

CDK1

−3.06

CYP3A7

2.40

RRM2

−3.03

NEFH

2.39

CDCA3

−2.93

  1. Ingenuity Pathway Analysis (IPA) was used for functional analysis of 1198 “Analysis Ready” (AR)-DEGs from the D2FAST48h vs. D3REFED24h contrast. The top 10 up-regulated and down-regulated AR-DEGs are presented along with their respective log2 ratio of treatment conditions